NCT02813135 2026-01-16ESMARTGustave Roussy, Cancer Campus, Grand ParisPhase 1/2 Recruiting472 enrolled
NCT05168904 2024-02-08A Study to Investigate Fadraciclib (CYC065), in Subjects With Leukemia or Myelodysplastic Syndrome (MDS)Cyclacel Pharmaceuticals, Inc.Phase 1/2 Suspended210 enrolled